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Abstract
Introduction: In settings with low literacy levels ensuring that participants are
fully-informed before they consent to participate in clinical trials is a challenge.
We explored the experiences and concerns of key actors in the informed consent
process in two HIV clinical trials.
Method: Semi-structured interviews were conducted with 46 respondents
including trial participants, research study team and research ethics committee
members about their experiences during the informed consent process. Three focus
group discussions were conducted with 14 Community Advisory Board (CAB)
members and 17 trial participants. Data were analysed to identify key themes.
Findings: The consent process was highlighted as an important procedure by all
the key actors however each group had a particular area of emphasis. Signing a
consent form was given importance by research team and ethics committee
members, because it provided documented evidence of a participant’s willingness
to join a clinical trial. Participants did not welcome the presence of a witness for a
non-literate participant because understanding study information was not closely
related to an ability to read and write.
Conclusion: This study’s findings indicated that obtaining a volunteer’s signature or
thumbprint on a consent form did not necessarily mean that the participant was fully-
informed about the information relevant to their taking part nor that they understood
all the information shared with them. Informed consent requires sufficient time in the
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research process to have staff trained well enough before research begins. Ensuring
and gaining informed consent should be understood and treated as a relation-centred,
dynamic supportive process throughout the duration of a research study.
Keywords: Social sciences, Health sciences, Medicine
1. Introduction
Requiring participants to sign a consent form is currently expected practice in clinical
trials as a way to ensure participants can be seen to have freely agreed to take part in a
trial as the best judges of their own interests [1]. However what the different actors
experienced during the informed consent procedure is usually not discussed.
Researchers have reported that voluntariness may be attained by participants within a
complex context whichwill include political, cultural, social and economic factors [2]
which may not reflect researchers’ and regulators’ assumptions. This paper focuses
on the perceptions of the different actors in the informed consent process on their
experience of managing the procedure of signing a consent form in two HIV clinical
trials in the Uganda context. The actors in the informed consent process examined
here include: the research team, the trial participants, the Regulatory Ethics
committee (REC) and the Community Advisory Board members (CAB).
Informed consent is usually seen as incorporating four components: disclosure of
information, the prospective participant’s comprehension to make an informed
decision, the participant’s being free from coercion, and a participant’s giving
consent explicitly and formally usually in written form ([3], [4], [5], [6]). In this
paper, the term ‘informed consent' will be used to refer to researchers giving full
information about what is involved in conducting an HIV clinical trial and ensuring
that the person receiving the information has the capacity to make a decision and is
voluntarily consenting to take part when he/she is satisfied that they have
understood the information [3], [7], [8]. Therefore, in this paper, as well as
receiving information on the study and signing the consent form, the ‘informed
consent process’ includes, all the interactions that occur during a research process
which inform a participant about the study.
Formal records of informed consent are widely seen as formal evidence that a
volunteer’s autonomy was respected and that they made an autonomous decision to
take part in the trial [9], [10], [11]. The primary goal of ensuring informed consent
is to protect participants’ welfare and respect their individual autonomy [12]. This
involves recognising a person’s capacities and perspective on what happens to
them during research, including accepting their right to hold certain views, make
certain choices and act based on their personal values and beliefs [7], [13].
‘Autonomy’ is a challenging concept which can be interpreted differently by
different disciplines. Appelbaum et al. ([14] (1987: 22) define it as ‘personal
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freedom of action or the right to do as one pleases within certain restrictions’.
However, personal freedom to make decisions is sometimes affected by the
environment in the community where the individual lives; because decision
making in most African communities is embedded in social relations and
influenced by culture, gender and values upheld in a particular setting [15, 16, 17].
The public health facilities and health services in Uganda are still insufficient for
the general population; there are few doctors and nurses to take care of the huge
population and drugs are not always available in the public health centres [18].
However, the research clinics which conduct research are part of the environment
but the clinics are usually better-equipped with the necessary facilities and have
well-trained health workers who are usually economically more advantaged and
have better education levels than most of the research participants. In a study
conducted in South Africa, the researchers found that sometimes patients
relinquish their autonomy and depend on the health workers decisions about their
health because they think health workers are competent in what they do [19].
International and National Human Research Guidelines require that consent be
formal and documented [1], [20], [21] as evidenced by a participant/patient’s
signature on a consent form. Findings from a demographic health survey in Uganda
showed that there are still some Ugandans that have either no formal education or
only primary level education. The proportion of female and male with no education
increases with age; for example, 12% of women aged 25–29 have never attended
school, compared with 59% of women aged 60–64 [22]. Given the high percentage
of the population who cannot read and write, the process of getting signatures is
unlikely to be easy. Although literacy is not equivalent to actually comprehending
study information, it influences the consenting process because it affects the
involvement of both the participant and a witness.
In this paper, we discuss the views of different actors in the informed consent
process and their experiences of informed consent. Specific reference is made to
the procedure of signing a consent form and the role of a witness during this
process. We explore views and experiences of respondents with participants who
are non-literate. Here we use the word “non-literate” only to mean someone being
unable to read or write, not as being otherwise limited in their wider understanding,
since limits in literacy skills cannot be assumed to limit understanding. The
findings inform the day to day practice of informed consent in HIV clinical trials.
2. Methods
2.1. Study design
The present study was a qualitative exploratory research project nested within two
HIV clinical trials, and it sought to explore what happens when implementing the
informed consent process within these clinical trials. The respondents were
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purposively selected to include the key actors in the informed consent process in
the two HIV clinical trials.
2.2. The trials in which this study was nested
Trial One was a phase I double-blind placebo-controlled trial to evaluate safety and
immunogenicity of two HIV vaccines with HIV-1 uninfected adult participants.
The participants in the trial were adults aged 18–40 years.
The second trial, investigated a Phase IV randomised trial evaluating the safety of
discontinuing treatment with Cotrimoxazole (septrin) prophylaxis among HIV-
infected adults on ART in Uganda. The participants were adults aged 18–59 living
with HIV who were already stabilised on ART and had a CD4 of over 250 cells.
2.3. Study area
The research was situated at two Medical Research Council/Uganda Virus
Research Institute (MRC/UVRI) Uganda Research Unit on AIDS sites. One of the
trials was in a semi-rural area and second trial was conducted in a semi-urban area.
Both sites were in the central region of Uganda and are about 139km apart.
At the Trial One site, most of the population were involved in peasant farming
producing cash crops including maize and coffee. Trial Two was situated near the
shores of Lake Victoria where the population were mainly fisher folk involved in,
fishing and selling fish, food business and running small kiosks were the other
main activities. Both areas have been affected by HIV, with some participants
currently living with HIV and others having lost close family members, friends and
neighbours to AIDS.
2.4. Selection of respondents for the qualitative study
There were five categories of respondents in this study who were purposively
selected in relation to their having different roles in the informed consent process
comprising: the research team (counsellors, nurses, clinicians, mobilisers and
senior researchers), the Research and Ethics Committee (REC) members, the
Community Advisory Board (CAB) members, the trial participants and their
spouses or close friends. This purposive selection therefore enabled an
understanding of the informed consent process from the different perspectives
relating to these key roles. In this paper we do not present findings from spouses or
close friends because there were very few interviews in this category and those
interviewed focused on the spouse or friend’s support to trial participants.
Research Ethics Committee (REC) members were included because they approve
the trial protocols and the participant information sheets and consent forms. The
REC is responsible for monitoring approved studies. The REC members were
Article No~e00196
4 http://dx.doi.org/10.1016/j.heliyon.2016.e00196
2405-8440/© 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
approached by the first author, who discussed the study and requested for
appointments for the interviews. The first author conducted the interviews with
each of the selected members after they consented to take part in the study. The
REC was represented by 5 members from different disciplines which included:
statistics, public health, social science, clinical/epidemiology and a community
representative.
The research team members were selected for this study because they implement
the research protocols and conduct the trial procedures. They have the greatest
interaction with the participants who join the clinical trials. The research team
included the senior scientists who were co-investigators and coordinators of the
trials and the study team for each of the trials included counsellors/health
educators, nurses, clinicians and mobilisers. The research team was approached
after the investigators had agreed to the inclusion of the trials in the qualitative
study. Each of the research team members was approached individually to seek
their consent for the interview.
The Community Advisory Board (CAB) members were included in this study
because they advise on research taking place in their community. They are a link
between the community and the research team. The CAB gives feedback to the
research team concerning what is happening in the community and they also
inform the community members they represent about what is happening at the
research centre. CAB members were approached through the community liaison
officer and they individually consented to take part in the study by signing a
consent form. The CAB members were invited to participate in a focus group
discussion. The CAB had representatives from the district medical office, health
centres around the research unit, other HIV and AIDS research and service
providers in the community, religious leaders (Christian and Muslim) and local
community leaders.
The trial participants included in this studywere thosewhowere already taking part in
the two HIV clinical trials and consented to take part in the qualitative study. The
inclusion criteria for participants in the qualitative research required that:
• the trial participants had to have been in the trial for at least 6 months,
• they were willing to give additional time in addition to the time spent in trial
activities
• they were willing to be interviewed at least three times for this study every three
months
• they were willing to sign a consent form to participate in the qualitative study.
Participants were first approached by the research nurses in the two clinical trials
since they were already involved with the participants. The nurses informed the
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participants briefly about the qualitative study which was to be nested within the
clinical trial. The participants, who were ready to hear more about the qualitative
study, met the first author and discussed the study information and then each
volunteer who consented to take part in the interviews and focus group discussions
signed a consent form. When a volunteer consented to take part, he or she was
interviewed and the next appointment for the second interview was made and at the
second interview, a third appointment was made. In both trials follow up was every
three months, so this project fitted in with that schedule. Two participants, a male
and a female, declined participation because they did not want to give additional
time for research.
2.5. Data collection and analysis
To gain an understanding of how the different actors in the two HIV clinical trials,
experienced and managed the informed consent process, the first author (AS)
conducted semi-structured in-depth interviews and focus group discussions with
them. The interviews and focus groups were audio-recorded. The first author
moderated the FGDs with a research assistant. The first author is a Ugandan and
the FGDs and interviews were conducted in the vernacular language common in
the two research sites. The respondents in this study were all aged 18 years and
above. The research team and the REC members were interviewed once by the first
author and the interviews were conducted in English apart from the community
representative where the local language and English were used.
The trial participants were interviewed three times by the first author, the first
interview was conducted when they consented, and the second and third at three
monthly intervals. Data collection lasted for one year from January to December
2012. See Table 1 for categories of respondents and data collection methods.
Data were downloaded from the digital recorder each day and then transcribed and
saved on a secure drive. The transcripts were first reviewed manually by the first
author in order to extract codes. Initial codes were generated from the first six in-
depth interviews which included two from the trial participants, two from the
research team, and two from the REC members and discussed with the second and
third authors of this paper. The initial codes were then applied to the whole data set
[23], [24], [25]. Data analysis was on-going and inductive throughout the data
collection process. Data analysis was aided in later stages by the use of NVivo 8
qualitative software in order to manage the coding.
2.6. Ethics and permissions
This study was reviewed and approved by the Science and Ethics committee (SEC)
of the Uganda Virus Research Institute and the Ethics committee of the School of
International Development at the University of East Anglia (UEA) in Norwich in
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the United Kingdom. It was cleared by Uganda National Council for Science and
Technology (UNCST). The respondents were involved in clinical trials and
permission was sought through the different trial steering committees and the site
principal investigators before the respondents were approached.
All the interviewees gave individual consent to be interviewed by signing a consent
form. To preserve anonymity, while reporting findings, we refer to Trial One or
Trial Two as the trial to which each respondent contributed, and use pseudonyms
so as not to reveal actual names of respondents.
The results presented in the following sections cover responses from the different
categories of actors in the informed consent process: the trial participants, the
research team, the REC and the CAB. The results are presented for all the actors in
relation to the sub sections: demographic characteristics, roles in the consent
process, comprehension of study information, significance of signing a consent
form, views on using thumb prints and witnesses and suggestions to improve the
informed consent process.
3. Results
3.1. The demographic characteristics of the study respondents
A total of 63 respondents took part in this study. The selection of the research team,
the research and ethics committee members and the community advisory board
members depended on their roles in the trial. The demographic characteristics of
the research team, ethics committee and the community advisory board members
were not collected in this study. See Table 1 for respondents in this study.
Table 1. showing data collection and category of interviewees.
Activity Study Site Category of respondent No. of respondents Gender
In-depth interviews (audio-recorded) 1 Senior scientists
Counselors
Nurses
Clinician
Community mobiliser
Trial participants
2
2
3
1
1
13
M
M, F
F
M
M
7M, 6F
In-depth interviews (audio- recorded) 2 Senior scientist
Counselors/health educator
Nurses
Clinicians
Trial participants
1
2
2
2
11
M
M, F
F
F, M
3M, 8F
In-depth interview(audio recorded) REC 5 3M, 2F
Focus group discussions
(audio recorded)
1
2
Trial participants
CAB
Trial participants
9
14
7
4M, 5F
7M,8F
1M, 6F
Short interview Spouses 4 3M, 1F
Article No~e00196
7 http://dx.doi.org/10.1016/j.heliyon.2016.e00196
2405-8440/© 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
The research team was composed of professionals who included scientists, nurses,
counsellors/health educators, clinicians and a community mobiliser. The REC
members were professional and a community representative who lives in one of the
communities where one of the trials was being conducted. The CAB had members
who were professionals and lay community and religious leaders. The trial
participants had various skills ranging from professional to vocational as presented
in Table 2 which shows their demographic characteristics. See Table 2
The mean age of the trial participants in this qualitative study was 32.6 (33) years,
ages ranging between 19–50 years. All the participants reported that they had attained
some level of education but for the majority this was limited to the primary school
level. As was reported in the Uganda national literacy statistics where female are less
literate than male [22], we found a similar pattern with the participants in this study,
11 (91%) out of the 12 who had primary education (first seven years of schooling)
were female; and some of these had some difficulty writing their names and their
reading was quite slow even in the vernacular. The female participants were mainly
doing casual work which in this context pays less money than formal employment.
The male participants in this qualitative research had low income paying jobs and the
university under graduate was not yet employed.
The participants in Trial One were in regular sexual relationships reflecting the
inclusion criterion for the trial and each of the participants had a spouse who had
been tested for HIV. In the qualitative study, this was not a criterion and the
participants were recruited as individuals. The participants in Trial Two had
varying marital status: married, separated, widowed and single because the main
inclusion criteria for the second trial did not involve a sexual partner. The inclusion
Table 2. Demographic characteristics of the Trial volunteers in this study.
Demographic characteristic Numbers
Sex 9 male, 14 female
Age Aged from 19–50 years Mean age is 33 years
Marital status Married 10(4F,6M)
Single 7(4F,3M)
Widowed 3
Separated 3
Education level Primary level 12(11F,1M)
Secondary 4(2F,2M)
Vocational 5(1F,4M)
University 1M
Occupation Small business- 12(11F,1M)
Students 2(1M,1F)
Formal employment 2M
Casual worker, 5(3M,2F)
House work (2F)
Unemployed (1F)
Saloon, roadside selling, shops
University, vocational
Security officers
Driver, School cleaner, motor vehicle mechanics
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criteria for the participants to join the trial were that they had tested HIV positive
and also met the other inclusion requirements of that trial.
3.2. Roles of the different actors in the informed consent process
As part of understanding informed consent, respondents were asked to discuss the
roles of the actors in the informed consent process. All respondents described the
trial participant as central to the informed consent process:
I think the person at the centre is the volunteer [participant], because . . .
[one,] this is somebody who is supposed to come in willingly; two, he has rights
which he may not be aware of and yet these rights should not be compromised
at any time and without him or her no study can take place, even if you have all
the money. (Robert, scientist, Trial One)
The participants often displayed a precise awareness of their contribution to the
process:
My role is important because if we don’t enrol then who will they conduct the
research on? Will they do it on animals? So that all shows that the research
team has to handle us well. (Susan, participant, Trial Two).
Another participant explained the importance of her involvement as a way of
encouraging other people to join research:
My main responsibility is to avoid getting HIV and to discuss information that I
have with other people . . . after this experience when I meet people and there is
research being done, I encourage them to join. (Fiona, participant, Trial One)
The CAB members reported that their role was to support the research team in the
selection of trial participants. They said they are the mobilisers in the community.
REC’s involvement in the informed consent process was more involving at the
time of protocol review before the trials were implemented. After the approval of a
given protocol, they are less directly involved in managing the consenting
procedure. The REC is however mandated to carry out monitoring visits to the sites
where approved trials are conducted.
3.3. Views on the comprehension of study information by trial
participants
Researchers have tried out several ways to try to assess volunteer understanding
which include quantitative tests and narratives, but it remains challenging to ensure
participants understand study information [9]. When discussing comprehension of
study information between the literate and non-literate participants; most
participants reported that it did not matter whether they signed or thumb-printed on
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a consent form; what was important was the potential participant being able to
understand the information given by the research team. A number of trial participants
highlighted that participants ‘comprehension’ and ‘signing consent form’ were two
different aspects of the informed consent process as one of them put it:
We need to know that both a person who has understood and one who has not
understood can sign. (Doreen, participant, Trial One)
This quote indicates that at least some participants saw it as possible for
participants, whether they could write or were only able to thumbprint the consent
forms, to join a trial without understanding the preliminary trial information.
The research team members indicated that although they may have found it easier
to deal with a participant who could read and write and so sign the consent form
easily without requiring a witness, they did not see those who could not write as
necessarily understanding the study information less well:
There are participants that never got the opportunity to go to school, but they
have common sense and they will reason things out much better even than
those who have been to school, so I do not see the difference . . . (Aida,
clinician, Trial Two)
For the REC members what was critical was that a participant understood the study
information and was protected by the researcher from social and physical harm as
has been outlined in guidelines [26]. The REC members mentioned the importance
of voluntary participation. They noted that participants’ understanding of the study
information should not be linked to their ability to read and write, because even
those who could not read could understand information if it was provided to them
in simple clear terms.
CABmembers noted that although signing of the consent formswas very important to
the researchers and was seen to imply that the individual had understood the study
information; in this community if the influential people in the community such as
religious leaders and some cultural leaders endorsed an activity themajority of people
would follow what their leaders have approved. Such communal decision-making
would then be based on the beliefs and values of these influential persons rather than
individually-informed decisions, similar to what has been reported elsewhere [27].
Religious leaders were singled out by the CAB members as very influential and
trusted by the majority of the people in the communities.
3.4. Perspectives on significance of signing and thumb printing
the consent form
Conducting clinical trials requires following informed consent guidelines most of
which require that trial participants sign a consent form before getting involved in
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any trial [21, 28]. Each of the actors was asked what the significance of signing or
thumb printing a consent form meant.
All the trial participants in this study noted that it was important that they sign or
thumbprint the consent forms and that documenting this informed consent was also
needed to indicate that they had joined the research freely. While discussing the
reasons why they needed to sign a consent form, the majority of the participants
argued they did this to show that they had not been coerced to join the research and
it would protect the researcher in case a volunteer experienced side-effects.
Most trial participants discussed signing or thumb printing the consent forms
matter-of-factly, as a usual procedure, perhaps indicating that they were used to the
way research studies are run by the MRC. That however, might mean that they
actually considered signing a consent form before they consider the key trial
messages discussed with the trial research teams at the start of a trial. One male
participant asked the first author (AS) to let him sign a consent form even before
they discussed the study information sheet because he explained that he trusted the
researcher.
The research team suggested four main reasons why it would be important for
participants to sign the forms: participation without coercion, legal agreement,
accountability and the protection of researchers. However each of the research
team members emphasised one or two of these aspects in relation to their role in
the informed consent process; the nurses, counsellors and mobilizer saw signing
the consent forms as significant in providing evidence to formally demonstrate that
the participants were participating in a study without being coerced and had
understood the information the research team had given them.
Senior researchers described a signed consent form as protecting them from being
suspected of having coerced a participant:
I think they need to sign, or else someone can easily deny that they agreed to
participate in your data. If they say they did not agree, what evidence do you
have to show that they actually agreed to participate in your study? (Festo,
Scientist, Trial Two)
The clinicians and scientists described the signed consent forms as evidence of the
discussion of the research information that happened between the potential
participant and the researcher. The signed consent form would also confirm the
existence of an agreement between the researcher and the participant about taking
part in a research.
One of the clinicians noted that a researcher who signed the consent forms was
taking responsibility within the research study for keeping the participant from
physical and social harm and ensuring the participant’s confidentiality.
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One research team member said that signing the consent forms served both the
researcher and the trial participant; “For the researcher, the signed consent form
was a record to show that the volunteer participated freely and for the participant
they were a record that they could show to others to demonstrate their
participation in research”. However, sharing of records was not common for all
the participants. During the focus group discussions, some participants reported
that they had kept their involvement in research as a secret because of the stigma
attached to research which was about HIV and AIDS.
The signed forms provided evidence for the researcher to the regulatory authorities
and study monitors that the participant had been informed about the risks of the
trial. However, one of the scientists remarked that the signed consent forms did not
reveal to someone outside the process what had transpired between the researcher
and the participant during the individual information sharing session:
It is a sign that something has happened. It does not tell you what happened; it
does not tell you the details of what happened . . . it does not tell you whether
I gave the information very well; it does not tell whether the person understood
everything; it just tells you yes, there might have been a process and you know
the two people signed. (Robert, scientist, Trial One)
These findings confirm that signing or thumb printing the consent forms as
discussed by the research team was an obligation set for them by the regulatory
authorities which the research team had to fulfil if they were to be seen to adhere to
the national and international ethics research guidelines [1], [21].
The interaction and trust built between the two people who signed the consent
forms, the research participant and the researcher was reflected in the related
discussion as more important in encouraging on-going participation of the
participants in a trial than the documents they signed, even though the latter
provide documented evidence.
The focus group discussion with CAB members suggested that one of the main
reasons for participants signing the consent forms was to protect the research team
from being sued in courts of law for not communicating the right information to
participants about possible negative effects of the trial products. They saw a signed
consent form as a source of legal cover for the researcher:
. . . if a [participant] has a problem along the way they cannot take you to
court because they agreed . . . For example if someone in the vaccine trial
got another disease they couldn’t just blame the organization. (CAB, FGD)
The CAB members commented that signing the consent form implied that the
signatory had received the study information and had agreed to be part of the study,
whether the trial result was positive or negative. CABmembers discussed that signing
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a consent form was useful for the research team when following up participants
because some may have similar names and the signatures help show the difference.
CAB members compared signing or thumb printing a form to a land-buying
transaction, which was common in this community. The CAB members speculated
that if nothing was signed to show that there was an agreement between the
researcher and the participant, this may have meant that no discussion of the study
information had taken place between the research team and the participant. A CAB
member quoted an expression commonly used in the community to express this:
We have a certain project working on quality improvement, and we have a
slogan that says ‘anything not documented is not done’. However much you
may work, until you document it is not done. If you gave verbal consent you
didn’t write it [and so it is not done] (CAB, FGD).
3.5. Views on thumb printing on a consent form
In this particular research context, usually a number of research participants are
unable to read or write on documents, so they have to thumb print on the consent
form in the presence of a witness. A recent Uganda National Household survey
showed that the overall literacy rate of Ugandans aged 10 years and above, was
71%, with men being more literate at 77% and women at 65% [22]. This meant that
adopting differing processes for achieving and recording informed consent
according to literacy levels might lead to varying experiences of informed consent.
While discussing views on whether to sign or thumb print a consent form, the
participants suggested it might give them a higher status among their peers if they
could sign the consent forms with their names, rather than putting a thumb print on
it. A male participant mentioned that thumb printing may be used in banks, but did
not see it as acceptable to ask a research participant to put their thumb print on the
consent forms, when they were able to write their name, because this meant they
were literate and therefore had the ability to sign on the consent form. Some of the
participants, however, said it would be acceptable to them to either sign or thumb-
print on a consent form as long as they had understood the trial information.
Four of research team members interviewed saw it as generally easier to deal with
literate than with non-literate participants during the information sessions and
consenting procedure. The research team said this was because where a thumbprint
had to be used they needed to find someone to witness the participant’s thumb
printing, making the process more complicated for the research team to manage
signing:
[Signing] shows an independence − that I have read this myself and I am
signing it . . . For those who thumbprint there is that traditional element: you
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must have a witness because you read to them and then someone has to
thumbprint and the witness signs . . . So it introduces another person, and
you usually have to make sure they understand what this person understands,
and this adds another dimension. (Robert, Scientist, Trial One)
However, this quote also illustrates how introducing a witness for a non-literate
participant during the consent process could reduce the participant’s autonomy as a
third person was introduced into their discussion with the research team member.
The participant lost some of their independence to make their own decision
because the witness had to be present while they were being given information and
when they thumb printed to join the research. It also added to the research team
member’s workload because they also had to ensure that the witness had
understood the study information before they signed for the participant.
REC members argued that thumb printing was not a disadvantage to the trial
participant. One committee member commented that it would be fine if all
participants thumb printed on the consent forms because no one could forge or lie
about another person’s thumb print.
3.6. Views on the role of a witness in the informed consent
process
The presence of a witness is particularly required by the Ugandan regulatory
authorities when a non-literate potential participant is being given information
about the study by the research team and during the consent procedure [20, 21].
The presence of a witness during the consenting procedure is intended to ensure
that the non-literate participant’s autonomy was being respected by the researcher.
The witness had to ensure that the participant they were witnessing for understood
the study information and agreed to the requirements of a trial before they gave
their consent.
Participants attached stigma to thumb printing, mainly because it involved the
presence of a third person as a witness. During the focus group discussion, the
participants mentioned that an adult who was not able to write might well find it
embarrassing to get a witness among those from the same community, some of
whom may be looking up to him as an elder. Social stigma being enacted in these
community settings has also been reported elsewhere and it can affect potential
participants [29].
The research team saw the issue of providing witnesses to the informed consent
process as difficult to manage, both for the participant and for the researcher
involved in facilitating their consent. Challenges were identified by some research
team members from their experiences of the consent process for participants. They
observed that participants might not want anyone other than the researcher to know
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that they could not sign or write their name. They identified challenges for them in
managing the research process from having to involve two people, the non-literate
participant and his or her witness to obtain consent ensuring that both understood
the study information. This requires communicating successfully with both
individuals.
Ideas about who should act as a witness to a non-literate participant’s consent
varied among the research team. Whereas some felt it was all right to use any
witness as long as the participant agreed, even if they did not previously know the
witness, some thought that the witness should be someone the volunteer knew:
The best would be a person close to the participant, someone who cares, a
person who loves the person, has known this person for some time, or a person
who benefits from the welfare of this patient to the extent that if the patient is
disadvantaged due to participating in research, then this person is also
disadvantaged because of that. (Timothy, Health educator, Trial Two)
The appropriate witness for a non-literate participant was therefore often described
as a person who would scrutinize the study information on their behalf and could
analyse the benefit and risks to the participant. The health educator noted that a
witness involved during the consenting process might not be answerable to the
participant if the latter was harmed during the research; in such a situation the
witness’s responsibility would be seen as ending with the signing of the consent
forms [12].
Some research team members felt that the participants were disempowered by their
reliance on the study team to pick a witness, although they may have agreed to or
refused to have the person proposed. The partial loss of the research participant’s
decision-making power could also affect their self-determination later in the
research project [14].
The research team found the process of securing witnesses for non-literate
participants to be onerous because they had to include a witness for each non-
literate participant before they could proceed with the consent process. This was
even more challenging if the witness was a fellow-participant who would be free to
choose to opt out or withdraw from the trial at any time. In such a situation, the
research team had the view that it would impact on the non-literate participant’s
continued participation in a trial, since the witness was seen to be a support for the
non-literate participant. In contrast, the research team members said that if a
witness was a neutral person who was not a close relative and was not in a trial,
they might be much less likely to understand what a participant went through in
taking part in a trial and might not give appropriate social support. These were
important issues for the research team to achieve the participant’s autonomy in the
informed consent process.
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REC members explained that because they did not supervise the informed consent
process directly it was difficult for them to confirm that there was a witness who
also understood the study information before signing for a non-literate participant.
The committee had to trust the researchers’ reports about consenting participants.
3.7. Concerns reported during the informed consent process
The research team noted that as well as the challenges in involving a witness for
the participants who could not read or write the research teams reported having to
manage a different type of problem with another group of participants, who did not
really know how to read and write properly but insisted on signing the consent
forms. Their written signatures appeared different on the screening consent form
and the enrolment consent form because they were just learning to write their
names.
Some other elements of informed consent which were of concern to the research
team included: getting an adequate thumb print, suspicion of the consenting
procedure for research by some participants who did not understand why they had
to sign or thumbprint if they had already verbally agreed to take part in a trial,
explaining technical terms in lay terms, and strict time lines which gave the
research team little time to fully understand study information before they shared it
with the participants.
The challenge of getting thumb printing right was noted by a clinician:
You roll your thumb from one side to the other, but [participants] become kind
of stiff, they just make a small spot, and this one is kind of twisted, . . . In the
end when you compare their thumbprints they don’t look the same. (James,
clinician, Trial Two)
Although participants agreed to participate in a trial some research team members
reported that participants usually joined expecting one specific procedure and that
it could be difficult for the researcher to get a participant to understand the other
procedures before consenting, to take part in the trial:
In my experience, during the informed consent process when you give people
information about what you are studying they lock onto something and . . .
that is what they use to join your study. You are going to tell them ‘we are
going to do A, B, and C’ − they lock onto something, maybe A, and it is what
they base joining your study on. (Festo, scientist, Trial Two)
Some research team members found it difficult to explain some of the factual
content on the study information sheets to the research participants for example:
We had about four meetings . . . so that we could understand . . . There is a
paragraph which states: ‘ . . . it is not known whether your risk of acquiring
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HIV infection will increase, decrease or remain the same’; that statement
really confused us, and the participants. (Sylvia, nurse, Trial One)
The CAB’s main concerns about the informed consent process were to ensure the
participant from the community was protected from both social and physical harm.
Their emphasis on the presence of “important persons”, like the religious and
cultural leaders in the community, who may influence decisions is an important
aspect for community engagement.
Table 3 sets out a comparison of responses from the different actors in the
informed consent process.
4. Discussion
This study investigated perceptions and experiences of the different actors in the
informed consent process with particular reference to participants’ comprehension
of study information, significance of signing a consent form, issues about
providing a thumb print and the involvement of a witness in the consenting
procedure. The national and international consent guidelines require that research
participants give written rather than oral consent [1], [20, 21]. This is intended to
ensure that the potential participant has understood the study information relating
to the aim and objectives and decides freely to take part in the research. We found
that all actors including the research participants in this qualitative study viewed
the signed consent form as a legal document binding the researcher and the trial
volunteer in an amicable relationship for the duration of the trial.
Trial participants did not mention information related to study content, such as the
trial objectives and procedures, as reasons for signing a consent form, despite this
being one of the basic reasons for ensuring informed consent. While a signed
consent form met the stipulations of informed consent guidelines, the form
recorded nothing about what was involved when researcher and participant
discussed the procedures of a trial. The form therefore gave no indication of the
volunteer’s comprehension of study information. While testing comprehension is
given explicit importance in clinical trials, the “when” it is done will also be
critical as noted by one participant. If testing for comprehension of study
information was too soon it may have reflected that a participant is able to recall
words but not with certainty that they comprehended what information the
researchers gave them.
The study revealed that there could be varying reasons why participants signed a
consent form. If participants were only concerned with signing the consent forms
as a prerequisite of joining a trial, this could mean that some of them did not
understand the implications of being a research participant in a randomised clinical
trial. While the researchers viewed the form as a literal basis for evidencing
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Table 3. Comparing responses from the different actors.
Actor Role in trial/informed consent
process
Overall values Definition of informed
consent
Views on consent form Views on thumb printing/
witness
Recommendations
Research
team
Give study information to
volunteer obtain consent from
volunteer −conduct study
procedures
Value is to recruit
and follow up
according to
protocol
Main emphasis is about
information giving,
agreement and signing of
consent forms
Helping volunteer to understand
design of trials not easy signing
of consent forms may be
viewed suspiciously
−volunteers join research for
usually one specific procedure a
volunteer whether literate or not
may/may not understand study
information Volunteers do not
necessarily understand
information at the start of a trial
−some find dealing with [3_TD$DIFF]non-
literate volunteers difficult in
communicating information-the
practice of getting the
thumbprint is difficult-some
believe a witness can be anyone
others say it should be a close
relative/friend
− involve literate family
members in the consenting
process-train research teams on
the importance of informed
consent-REC should do spot
checks-community engagement
should start early in
communities where volunteers
are to be selected from-the
literate peers among the
volunteers could participate in
information sharing sessions-
volunteers need at least a day to
two weeks to study the study
information provided to them
before they are requested to
sign on the consent form-need
for on-going discussions
between the actors(SEC,CAB,
Volunteers and research team)
Volunteer −take part in the research-
inform other community
members and interest them in
research
−value is attached
to altruism for some
and for some it is
about what benefits
particularly related
to their health well
being
−main emphasis is that
there are no risks to the
individual and benefit of
health care that may be
lacking in the public
health care clinics/
hospitals
− it shows a volunteer has
accepted to take part in
research-by signing a consent
form it does not mean that one
has understood the study-if any
one refuses to sign then it is an
indicator of refusal to take part
−thumb printing is stigmatised
in community
−understanding of study
information should be gauged
after they have been in a trial
for some time to avoid recall
bias volunteers need more than
a single information session-
information given to volunteers
should be clear and easy to
understand-interventions to
support literacy and numeracy
should be developed
REC Ensure the set national and
international research
guidelines are operating at the
Value is attached to
the effort of
ensuring volunteer
Emphasis is on follow
guidelines and safeguard
volunteer from any form
−it is the only way to confirm
that a volunteer agreed to
participate in a trial-signing or
The guidelines require this to
safeguard the volunteer-signing
and thumb printing is currently
−consent forms should be
short-contact information
should reflect researchers at the
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Table 3. (Continued)
Actor Role in trial/informed consent
process
Overall values Definition of informed
consent
Views on consent form Views on thumb printing/
witness
Recommendations
research sites-review protocols
and informed consent
documents-monitor what takes
place at the research sites
do not experience
any form of harm
(social and Physical)
of harm (physical, social,
emotional)-use simple and
clear language in consent
forms
thumb printing is not a problem
as long as forms give full
information and no harm done
to volunteer-do not relate
volunteer’s understanding to
ability to read and write
the only way the process is
documented and should
continue
sites-emphasise verbal
information before you
introduce documentation-
introduce visual aids like flow
charts to describe informed
consent process-
protect interests of the
community
CAB/
community
The main link to the study
population in the community-
gatekeepers to the community,
they support initial contact with
potential volunteers
Value is attached to
respect for the
individual and the
community
Emphasis is on free choice
for volunteer to take part
or refuse to take part-no
coercion
− signing consent forms is to
protect the research-signing
implies volunteer has accepted
to take part in the research
−if information is provided in a
language a volunteer
understands, whether one signs
or thumb prints both are
capable of understanding
information, so it does not
matter
−The activities of CAB should
be monitored to encourage
accountability-need frequent
meetings with research team-
they want a more active
involvement as stakeholders in
the community
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participant autonomy in the informed consent process the participants saw it more
as a document that they signed like a contractual agreement to join the research
study.
There are limits of the consenting process that a signed consent form can represent
as noted by one scientist since its outcome was so dependent on the interaction
between the researcher and the volunteer who sign the form. The discussion on
how to engage a participant until they made their decision to join a trial may not be
clear to the person who was not part of the interaction. He/she will not know what
was discussed, what was agreed upon and the kind of questions that were asked by
the participant before they agreed to sign the consent form.
This raises an important ethical issue for the “informed” aspects of “informed
consent” because the trial information given to the potential participant may only
have been limited in explaining scientific terms as reported by some participants.
This may imply that some participants may join a clinical trial without having
understood some aspects of the trial.
An ethical dilemma identified in this study relates to that arising from the varying
literacy levels of the participants in this context. In this setting, having non-literate
participants was not uncommon and therefore assessing participant understanding
of study information entailed several ethical dilemmas. These included assessing
volunteer understanding, individual and community stigma attached to thumb
printing on a consent form and the presence of a witness during the consenting
procedure for non-literate participants.
While using uniform tools to assess comprehension may have been important as
suggested by many researchers, the main contributing factor to participants’
understanding study information and key concepts is researchers using a language
that the participants would understand in the relevant context. This is similar to the
reports by Brehault et al., [30] that when information sheets were translated into
the local language of the participants, communication between the researcher and
the participant was made easier. Afolabi et al., [31] conducted a study to review
how informed consent comprehension is defined and measured in African research
settings and found that study participants’ comprehension of key study concepts
was poor, suggesting a need to develop a uniform definition for informed consent
comprehension after developing appropriate tools. This is indicated in our findings
that the trial participants requested that information discussed with them needed to
be simple and clear to enhance comprehension.
Our findings show that in this context there was stigma attached to thumb printing
a consent form rather than signing it off. In communities like these, where not
everyone in the community has had an opportunity to go to school, some
individuals might be exposed to stigma attached to those not able to write one’s
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name. Researchers might be less aware of this risk. A genetic study conducted in
Ethiopia recommended the need for investigators to seek to assess and address
risks of research as perceived by the prospective participants [29]. The participants
while not experiencing challenges with comprehending study information,
commented emphatically on the problems their fellow participants experienced
with thumb printing [28]. Failure to write one’s name on a consent form currently
means the presence of a witness will be routinely required during the consenting
procedure according to the regulatory ethics guidelines [1], [21], [26], [28], [32].
While this may have solved a researcher’s and ethics committee formal problem; it
would be likely to raise many other challenges for researchers and participants’
work and status.
Although signing or thumb printing was always carried out at the start of a trial, the
majority of respondents, including the trial participants, asserted that this also
affected the volunteer’s self-determination and autonomy, often for the duration of
the study [33]. Thumb printing by all participants in research could reduce the
stigma faced by the non-literate participants in trials.
The research team and ethics committee members also assumed that the witnesses
‘understood the information better’ than the non-literate participants and could also
help them understand it. They nonetheless noted that obtaining a thumbprint from a
participant took more time than a signature and that the presence of the witness
made the participant uncomfortable when they were thumb printing the consent
form.
The differences noted in perceptions of the different research team members
around what qualified a witness for a non-literate participant suggest this may
require more ethical discussion about the obligations that should be attached to
the role and who should be judged an appropriate witness in a given research
context.
Participant confidentiality and privacy during the research was less certain in
circumstances that involved a witness. Including a third party in the agreement
between the research team and the non-literate participant violated the latter’s
privacy according to some research team members. Even when they had
understood the study information the non-literate participant was also being
required to relinquish part of their power to make their own decision to take part in
a trial, to the witness at the signing of the consent form.
Of all the issues covered by the informed consent guidelines, the presence of a
witness when a non-literate participant formally consented to join the trial aroused
the most controversy in the individual interviews of all the actors and during the
focus group discussions, and yet this was a requirement laid down in the national
and international guidelines [1], [20], [21], [28].
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Our findings show that participants may join a trial after deciding to focus mainly
on just one aspect of the trial and to rely on their relationship with the research
teams. Other study findings in East Africa found that a participant may sign a
consent form because of the trust they have for a research member or focusing on
one aspect of the procedures of a trial [34], [35], [36], [37], [38], [39], [40],
findings which are similar to our findings in this study
Additional resources may be needed to build the capacity of research teams to
manage this requirement to consent participants, especially those who are non-
literate if they are to address the extra safeguarding and trust building activities by
researchers required as reported in this study. A similar concern was expressed
during a workshop on informed consent [41].
5. Limitations
The main study limitation was that there could have been some selection bias in
terms of who chose to take part in the qualitative study. However, the participants
were in a similar stage of their clinic scheduled follow-up visits and all the other
respondents took part in this study because of their role in the clinical trial.
Although the qualitative study was conducted with trial participants who had been
in research for at least six months, no observation was therefore made at the time of
their entry to the trials and the researcher could have missed the first time
experience of participants at the inception of the trial. The first author obtained
individual informed consent from all the respondents taking part in this qualitative
study.
6. Conclusion
It could be seen in this study that obtaining a participant’s signature or thumbprint
on a consent form did not necessarily mean that the participant who signed a
consent form was either fully-informed about the information relevant to their
taking part nor that they also understood all the information communicated to them
by the research team. The presence of a witness during the consenting of a non-
literate participant could also be seen to have put participants in a more- rather than
a less-vulnerable social position within the research process. When involving non-
literate people, the formal ethical requirements in the informed consent process
could be seen as subjecting such participants to stigmatising processes right from
the start of a research trial, while a participant was thumb printing while giving
consent, to the end of their involvement in the trial. Such potential for stigma may
mean higher risk that participation is not wholly voluntary. Thus, while the
formalised process of obtaining a signature and thumb print from a potential
participant may work successfully, in terms of gaining written record of consent
the study findings also show that the procedure may cause humiliation for the
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non-literate participants which may adversely affect participants who are
non-literate. Ensuring and gaining informed consent should therefore be
understood and treated as a dynamic, relation-centred, supportive process
throughout the duration of a research study to facilitate participant autonomy.
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